Bio*One Capital's A-Bio Pharma Secures A Second Deal With GlaxoSmithKline(18 Aug 2005) $9 million Expansion of Facility Underway Bio*One Capital Pte Ltd, a leading biomedical sciences investment management company, announced that its portfolio company A-Bio Pharma Pte Ltd (A-Bio), has clinched its second process development and clinical supply service agreement with ...
A-Bio Secures Major Deal with Novo Nordisk(01 Jun 2005) A-Bio Pharma Pte Ltd (A-Bio) announced that it has entered into a multi-year Master Service Agreement with Novo Nordisk A/S. Under the agreement, Novo Nordisk will engage A-Bio for process development and GMP clinical supply of biologics in its ...
A-Bio Announces Process Development and Clinical Supply Service Agreement with GlaxoSmithKline Biologicals(04 Nov 2004) Agreement with a World Vaccine Leader Marks Major Milestone for Singapore Biologics Contract Manufacturer Singapore. A-Bio Pharma Pte Ltd (A-Bio) announced that the company has entered into a process development and clinical supply service agreement with GlaxoSmithKline's vaccine division, GlaxoSmithKline Biologicals (GSK Bio) via the signing of an ...